ASAN Asana, Inc. Insider Trading

CFO Sonalee Elizabeth Parekh sells 108,544 shares of ASAN for $1.5M at blended avg $14.13; stock near 44% below 52-week high.

Parekh executed 2 separate sales totaling 108,544 shares for $1,534,225.32 on consecutive days (2025-12-22 and 2025-12-23) at an average of $14.13, reducing her stake by 10.1% from 1.08M to 968.1K shares. The stock is currently trading at $13.51, down 44.4% from its $24.28 52-week high, while the company reported a $68.4M net loss on $201.0M in quarterly revenue. Parekh's cross-ticker track record shows 7 prior sells with an average 90-day return of +8.9% and a well-timed rate of 14.29%, indicating that most of her prior sales have been poorly timed (stock rose afterward); at ASAN specifically, her 2 prior sales showed mixed results (1 of 2 well-timed at 90 days). The timing of this sale against the stock's depressed valuation relative to its recent range warrants attention, particularly given the company's ongoing unprofitability and the magnitude of the position reduction.

GC/Secretary Lacey Eleanor B sold 100,697 shares at blended avg $13.97 for $1.4M; holds 428.6K post-sale.

Lacey Eleanor B, General Counsel and Corporate Secretary, executed 2 separate sales totaling 100,697 shares for $1,406,235.79 on consecutive trading days (2025-12-22 and 2025-12-23), reducing her holding by 19.0% from 529,326 shares. The transactions occurred as ASAN trades at $13.51, down 44.4% from its 52-week high of $24.28, and within a 52-week range of $11.91–$24.28; the company remains unprofitable with a net loss of $-68,433,000.00 on quarterly revenue of $201,033,000.00. The near-simultaneous two-day sales represent a material reduction in her stake, executed near the lower end of the 52-week range despite the company's recent +11.1% 30-day price recovery, warranting investor attention to both the size of the disposition and the unprofitable operating context.

Asana COO sells 160,456 shares for $2.3M at $14.41 average as stock rebounds 18.3% in 30 days from depressed levels.

Raimondi executed 4 separate sales totaling 160,456 shares for $2,312,857.08 between December 18–22, 2025, reducing her holdings by 18.6% to 702,013 shares. The transaction occurred at a blended average price of $14.41, slightly above the current price of $14.38 but well below the 52-week high of $26.32 (stock is -45.4% from peak). In her prior ASAN sale on 2024-12-20, she sold near what proved to be a short-term inflection point; that trade showed 90-day underperformance of -35.5%, indicating a well-timed exit. The company remains unprofitable on a full-year basis with latest-quarter net income of $-68,433,000.00, though annual revenue growth stands at +10.9%. The timing and composition of these sales merit observation given the stock's 30-day recovery of +18.3% and the insider's prior demonstrated ability to identify downturns at this ticker, though the current sale occurs on the upswing rather than ahead of further deterioration.

GC/Corporate Secretary Lacey Eleanor B sold 100,000 shares of ASAN at $15.24; stock down 46.6% from 52-week high, company posting $-68.4M net loss.

Lacey Eleanor B, serving as General Counsel and Corporate Secretary, sold 100,000 shares at $15.24 on 2025-12-09, reducing her holdings by 15.9% to 529,326 shares. The sale occurs against a backdrop of material operational stress: Asana reported a $-68.4M net loss in its most recent full fiscal year despite 10.9% annual revenue growth to $201.0M, indicating widening unprofitability. The stock trades at $14.71 today, 46.6% below its 52-week high of $27.52, suggesting considerable value destruction since the insider's last significant baseline. While the stock has rebounded 10.7% over 30 days and 11.4% over 90 days, the broader context—sharply negative earnings, a $3.3B market cap company burning cash, and the executive's reduction of a substantial position—warrants investor attention to trajectory and burn rate trends.

Director Rosenstein sold 858,448 shares ($13.0M) in 2 transactions; post-sale holdings drop 80.3% to 210,398 shares

Justin Rosenstein, Asana Director, executed 2 separate sales totaling 858,448 shares for $12,978,252.19 on December 8–9, 2025, reducing his holdings from 1,068,846 shares to 210,398 shares—an 80.3% reduction. At the blended average price of $15.12, the transaction occurred when ASAN traded 3.7% above the current price of $14.58, though the stock remains 47.0% below its 52-week high of $27.52. His prior trades at ASAN show a 2-of-2 pattern of well-timed 90-day outcomes, but this sale post-dates the most recent measurable outcome, so near-term consequences remain unclear. Asana's fundamentals show unprofitability (net income of $-68,433,000.00 in the latest quarter and negative full-year net income), though the company achieved 10.9% annual revenue growth to $201,033,000.00, creating a context of operational losses amid modest growth.

Director Justin Rosenstein sells 458.9K ASAN shares ($6.9M) at $14.98; stock down 46.8% from 52-week high

Justin Rosenstein, a Director, sold 458,878 shares (29.8% of his pre-transaction holdings) at $14.98 on 2025-10-21, reducing his position from 1,541,425 to 1,082,547 shares. The sale occurred as Asana trades at $14.64, down 46.8% from its 52-week high of $27.52, and follows a pattern of repeated selling: Rosenstein executed two additional ASAN sales on 2025-10-09 and 2025-10-08 (outcome not yet measurable), plus three sales in late July that yielded negative 30-day and 90-day returns. His cross-ticker track record shows a 94.12% well-timed rate on 20 prior sells across all tickers, with average 90-day returns of -9.6%, indicating a historical pattern of selling before subsequent declines. At the same-ticker level, his two measurable ASAN sales (2025-07-25 and 2025-07-24) both posted negative 90-day returns, extending a pattern of well-timed exit points. The company remains unprofitable (net income of $-48.4M on $196.9M quarterly revenue) despite 10.9% annual revenue growth, creating fundamental headwinds that contextual timing patterns may reflect.

Director Justin Rosenstein sold 1,654,473 shares (51.5% of holdings) at $15.08–$15.23 for $25.1M; stock now at $13.63, -50.5% from 52-week high.

Director Justin Rosenstein executed two separate sales totaling 1,654,473 shares for $25,135,678.17, reducing his holdings from 3,210,398 shares to 1,555,925 shares (a 51.5% reduction). The sales occurred at $15.08 on 2025-10-08 and $15.23 on 2025-10-09, with a blended average price of $15.19. The current price of $13.63 represents a decline of approximately $1.56 from the transaction prices, placing the stock 50.5% below its 52-week high of $27.52. Rosenstein's prior sales at Asana all showed negative 30-day returns (ranging from -3.4% to -8.9%), and his cross-ticker track record shows 20 prior sells with a 90-day well-timed rate of 92.31%, suggesting a pattern of selling into weakness. The company remains unprofitable (net income of -$48.4M in the latest quarter) despite 10.9% annual revenue growth, which may be contextually relevant to the timing of this substantial position reduction.

CFO Sonalee Parekh sold 258,350 shares (258.4K) for $3,674,627.22 ($3.7M) at blended avg $14.22

On 2025-09-22 and 2025-09-23, Asana CFO Sonalee Parekh executed two separate sales totaling 258,350 shares for $3,674,627.22. Her post-transaction holdings remain substantial at 1,076,693 shares (1.08M), representing a -19.4% reduction in her position. The sales occurred in a market environment where Asana trades -48.6% below its 52-week high of $27.52 and the company remains unprofitable with a net income of $-48,360,000.00 in the latest quarter, though annual revenue growth stands at +10.9%. Her cross-ticker track record shows sells with an average 90-day return of +12.0% and a well-timed rate of 0.00%, indicating her prior open-market sales did not precede stock declines.

Director Moskovitz buys 122,470 ASAN shares at $13.52 amid -48.6% decline from 52-week high; repeated buys over 5 consecutive trading days.

Director Dustin A. Moskovitz purchased 122,470 shares on 2025-08-21 at $13.52, extending a pattern of daily acquisitions at this ticker—the SAME-TICKER HISTORY shows 5 prior buys on 2025-08-20, 2025-08-19, 2025-08-18, 2025-08-15, and 2025-08-14. The stock is currently trading at $14.15, down 48.6% from its 52-week high of $27.52 and down 20.9% over the past 90 days. Asana's fundamentals show the company generated $187.3M in revenue last quarter with annual growth of +10.9%, but posted a net loss of $40.0M and remains unprofitable on a full-year basis. His cross-ticker track record shows 20 prior buys with an average 30-day return of -5.7%, and the current stock is down 5.0% over the past 30 days—a pattern consistent with his historical outcomes. The consecutive daily purchases during a significant price decline warrant observation, as the near-term momentum remains negative and the company's profitability trajectory remains uncertain.

Director Moskovitz purchases 446,966 shares across 2 transactions for $6,139,843.78 at $13.74 blended price; stock down 50.2% from 52-week high.

Dustin A. Moskovitz, a Director at Asana, made 2 separate purchases totaling 446,966 shares for $6,139,843.78 on August 19–20, 2025, at a blended average price of $13.74. The timing coincides with a period of significant weakness: the stock is trading at $13.70, down 50.2% from its 52-week high of $27.52 and down 21.6% over the past 90 days. Asana remains unprofitable (latest quarter net income: $-40,018,000.00) despite 10.9% annual revenue growth to $187,267,000.00. Moskovitz's cross-ticker buy history shows an average 30-day return of -5.6% across 20 prior purchases, and his 5 most recent ASAN trades (all within a single week in mid-August) have not yet reached measurable outcomes. The filing reveals heavy near-term accumulation activity by a key insider during pronounced stock weakness, with no established pattern of accurate entry timing on this ticker to date.